A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
NCT02020226
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
TH-302
Sponsor
Threshold Pharmaceuticals